![Menarini Diagnostics UK > Home > Professional Diagnostics > COVID-19 > VitaPCR™ Platform OLD > Features Menarini Diagnostics UK > Home > Professional Diagnostics > COVID-19 > VitaPCR™ Platform OLD > Features](https://www.menarinidiag.co.uk/portals/11/Images/covid/vitaPCR_01.jpg)
Menarini Diagnostics UK > Home > Professional Diagnostics > COVID-19 > VitaPCR™ Platform OLD > Features
![Electropherograms showing on-chip HPA1 PCR (115 bp) products amplified... | Download Scientific Diagram Electropherograms showing on-chip HPA1 PCR (115 bp) products amplified... | Download Scientific Diagram](https://www.researchgate.net/publication/225622595/figure/fig2/AS:393776242675722@1470894980855/Electropherograms-showing-on-chip-HPA1-PCR-115-bp-products-amplified-from-purified-DNA.png)
Electropherograms showing on-chip HPA1 PCR (115 bp) products amplified... | Download Scientific Diagram
![m-TAG: a PCR-based genomic integration method to visualize the localization of specific endogenous mRNAs in vivo in yeast | Nature Protocols m-TAG: a PCR-based genomic integration method to visualize the localization of specific endogenous mRNAs in vivo in yeast | Nature Protocols](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnprot.2009.115/MediaObjects/41596_2009_Article_BFnprot2009115_Fig1_HTML.jpg)
m-TAG: a PCR-based genomic integration method to visualize the localization of specific endogenous mRNAs in vivo in yeast | Nature Protocols
Evaluation of potential COVID-19 recurrence in patients with late repeat positive SARS-CoV-2 testing | PLOS ONE
![NSW Health on Twitter: "COVID-19 weekly update – Friday 16 September 2022 In the 7 days to 4pm Thursday 15 September: -17,229 new cases of COVID-19 have been recorded: 10,162 rapid antigen NSW Health on Twitter: "COVID-19 weekly update – Friday 16 September 2022 In the 7 days to 4pm Thursday 15 September: -17,229 new cases of COVID-19 have been recorded: 10,162 rapid antigen](https://pbs.twimg.com/media/FcuxtOiakAEjNVK.jpg)
NSW Health on Twitter: "COVID-19 weekly update – Friday 16 September 2022 In the 7 days to 4pm Thursday 15 September: -17,229 new cases of COVID-19 have been recorded: 10,162 rapid antigen
![Electropherograms showing on-chip HPA1 PCR (115 bp) products amplified... | Download Scientific Diagram Electropherograms showing on-chip HPA1 PCR (115 bp) products amplified... | Download Scientific Diagram](https://www.researchgate.net/profile/Dammika-Manage/publication/225622595/figure/fig2/AS:393776242675722@1470894980855/Electropherograms-showing-on-chip-HPA1-PCR-115-bp-products-amplified-from-purified-DNA_Q640.jpg)
Electropherograms showing on-chip HPA1 PCR (115 bp) products amplified... | Download Scientific Diagram
![JCI Insight - Targeting IL-17A/glucocorticoid synergy to CSF3 expression in neutrophilic airway diseases JCI Insight - Targeting IL-17A/glucocorticoid synergy to CSF3 expression in neutrophilic airway diseases](https://df6sxcketz7bb.cloudfront.net/manuscripts/132000/132836/medium/jci.insight.132836.t1.jpg)
JCI Insight - Targeting IL-17A/glucocorticoid synergy to CSF3 expression in neutrophilic airway diseases
![Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study - The Lancet Respiratory Medicine Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/45431f6d-5869-429e-9e7f-b3d25a94d8f9/gr1.jpg)
Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study - The Lancet Respiratory Medicine
![Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy | Chinese Medical Journal Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy | Chinese Medical Journal](https://mednexus.org/cms/asset/00d46f8d-d925-456e-b2bc-40f115894f94/cm9.0000000000001876.png)
Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy | Chinese Medical Journal
![Bioengineering | Free Full-Text | Ultrafast PCR Detection of COVID-19 by Using a Microfluidic Chip-Based System Bioengineering | Free Full-Text | Ultrafast PCR Detection of COVID-19 by Using a Microfluidic Chip-Based System](https://pub.mdpi-res.com/bioengineering/bioengineering-09-00548/article_deploy/html/images/bioengineering-09-00548-g007.png?1666705803)
Bioengineering | Free Full-Text | Ultrafast PCR Detection of COVID-19 by Using a Microfluidic Chip-Based System
![FDA has released a total of 410 COVID – 19 Test Kits (133 – PCR based, 115 – Rapid Antibody, 73 – Immunoassay and 89 – Others - Food and Drug Administration FDA has released a total of 410 COVID – 19 Test Kits (133 – PCR based, 115 – Rapid Antibody, 73 – Immunoassay and 89 – Others - Food and Drug Administration](https://www.fda.gov.ph/wp-content/uploads/2021/04/08-April-2021.png)
FDA has released a total of 410 COVID – 19 Test Kits (133 – PCR based, 115 – Rapid Antibody, 73 – Immunoassay and 89 – Others - Food and Drug Administration
![Viruses | Free Full-Text | Maternal and Neonatal Outcomes of SARS-CoV-2 Infection in a Cohort of Pregnant Women with Comorbid Disorders Viruses | Free Full-Text | Maternal and Neonatal Outcomes of SARS-CoV-2 Infection in a Cohort of Pregnant Women with Comorbid Disorders](https://www.mdpi.com/viruses/viruses-13-01277/article_deploy/html/images/viruses-13-01277-g001.png)
Viruses | Free Full-Text | Maternal and Neonatal Outcomes of SARS-CoV-2 Infection in a Cohort of Pregnant Women with Comorbid Disorders
![Improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facility | Scientific Reports Improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facility | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-06873-6/MediaObjects/41598_2022_6873_Fig1_HTML.png)
Improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facility | Scientific Reports
![Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2–18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study - The Lancet Infectious Diseases Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2–18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/be536e03-b183-4dae-b0ba-c201cee95ee0/gr1_lrg.jpg)